Cancer and Metastasis Reviews - Introducing New Editorial Team
It’s our great pleasure to introduce our new editorial team at Cancer Metastasis Reviews.
Editor-in-Chief
Dr. Erica Golemis has worked in the field of cancer research for four decades. During this time, there has been an explosive growth in understanding of the root causes of cancer. Clinical translation of fundamental basic discoveries has supported the development of powerful therapies that have converted many cancers from lethal to chronic conditions and in some cases have resulted in cures.
Given the immense research efforts focused on controlling and eliminating cancers, timely and thorough reviews have become essential in summarizing burgeoning numbers of publications, identifying critical advances, and nominating directions for impactful future research. In joining Cancer & Metastasis Reviews as Editor-in-Chief, Dr. Golemis is committed to soliciting and promoting review articles of high value to the scientific community.
As biographical background, as a graduate student at MIT, Dr. Golemis identified enhancer elements driving leukemia virus pathogenicity. As a postdoctoral fellow at Massachusetts General Hospital and Harvard Medical School, she led the development of a two-hybrid system to identify and define protein interactions. Now, as the William Wikoff Smith Chair in Cancer Biology at Fox Chase Cancer Center in Philadelphia, she serves as Associate Director for System Integration; she also holds a second role as Chair of the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University. Her research focuses on the study of complex cancer signaling networks that influence tumor progression and therapeutic response and employs approaches from bioinformatics, high throughput screening, and classic cell and molecular biological approaches. Dr. Golemis is a Fellow of the American Association for the Advancement of Science. She has published over 240 articles and edited 4 books on topics in cancer and biotechnology.
“Cancer and Metastasis Reviews has played a valuable role and is currently in a strong position, poised to be a home for thought leaders in the next decade,” says Dr. Golemis. “It would be a privilege to contribute to the growth of the journal.”
Associate Editors:
Dr. Gary (Guangwen) Ren- Dr. Ren obtained his B.S. and M.S. in Microbiology at Shandong University. He then received his Ph.D. in Immunology from Rutgers University. He was awarded the Postdoctoral Fellowship by FM Kirby-CINJ Foundation, DOD Breast Cancer Research Program, and NIH/NCI Pathway to Independence Award while working under the supervision of Dr. Yibin Kang at Princeton University. He is currently an Associate Professor at the Jackson Laboratory. His research mainly focuses on elucidating how mesenchymal lineage cells (mesenchymal stem cells and fibroblasts) and immune-regulatory myeloid cells (neutrophils and macrophages) modulate the adaptive immune responses in cancer treatment resistance and metastatic relapse.
Dr. Qin Yan- Dr. Qin Yan is a Professor of Pathology at Yale Medical School and a member of Yale Comprehensive Cancer Center, Yale Stem Cell Center, Yale Center for Immuno-Oncology, and Yale Center for Research on Aging. He directs a research laboratory to elucidate the roles of epigenetic mechanisms that drive tumor initiation and progression and to translate their findings to the clinic. Dr. Yan received his B.S. degree from the University of Science and Technology of China. After his Ph.D. training on regulation of transcription and ubiquitination with Drs. Joan and Ronald Conaway at the Oklahoma Medical Research Foundation and Stowers Institute for Medical Research, he completed his postdoctoral training on cancer biology with Nobel laureate Dr. William Kaelin at the Dana-Farber Cancer Institute and Harvard Medical School.